Related Experiment Video

Updated: Aug 14, 2026

Vasodilation of Isolated Vessels and the Isolation of the Extracellular Matrix of Tight-skin Mice
08:09

Vasodilation of Isolated Vessels and the Isolation of the Extracellular Matrix of Tight-skin Mice

Published on: March 24, 2017

The immune regulation in familial Mediterranean fever (FMF)

A Melamed1, S Cabili, V Zakuth

  • 1Pediatric Department, Rokach Hospital, Tel Aviv Medical Center, Israel.

Journal of Clinical & Laboratory Immunology
|July 1, 1988
PubMed

Insights

Familial Mediterranean Fever (FMF) patients show an immune imbalance, with decreased T-helper and T-suppressor cells and increased NK cells. Monocytes produce more IL-1 and less IL-2, suggesting immune dysregulation in FMF.

Area of Science:

  • Immunology
  • Genetics
  • Rheumatology

Background:

  • Familial Mediterranean Fever (FMF) is a genetic autoinflammatory disorder.
  • Immune dysregulation is suspected in FMF pathogenesis.
  • Understanding immune cell profiles and cytokine production is crucial for FMF research.

Purpose of the Study:

  • To investigate potential immune regulation imbalances in patients with Familial Mediterranean Fever (FMF).
  • To analyze T-cell subsets, Natural Killer (NK) cells, and Interleukin (IL)-1 and IL-2 production in FMF patients compared to controls.

Main Methods:

  • Comparative analysis of T-cell subsets (supp T-cells, helper cells), B-cells, and NK cells in 39 FMF patients and 14 controls.
  • Measurement of Interleukin-1 (IL-1) and Interleukin-2 (IL-2) production by peripheral blood monocytes.
  • Subgroup analysis based on colchicine treatment and presence of amyloidosis.

Main Results:

  • FMF patients exhibited significantly decreased numbers of suppressor T-cells and helper T-cells compared to controls.
  • A significant increase in Natural Killer (NK) cells was observed in FMF patients.
  • Monocytes from FMF patients produced higher levels of IL-1 and lower levels of IL-2 than controls.
  • Cytokine production differences were more pronounced in subgroups with specific treatment and disease complications.

Conclusions:

  • Preliminary findings suggest a notable immune regulation imbalance in Familial Mediterranean Fever (FMF).
  • The observed alterations in T-cell subsets, NK cells, and cytokine profiles indicate immune dysregulation in FMF.
  • Further investigation is warranted to elucidate the relationship between amyloidosis, colchicine treatment, and immune alterations in FMF.

More Related Videos

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity07:09

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity

Published on: January 7, 2019

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis06:35

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

Published on: February 8, 2019

Related Concept Videos

Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
Malaria01:29

Malaria

Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...